Safety Study of Multiple Dose Administration of Sifuvirtide for Injection in Subjects with HIV Infection
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Sifuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors FusoGen Pharmaceuticals
- 01 Aug 2010 An update of FusoGen's sifuvirtide development programme was presented at a symposium in Beijing, according to a FusoGen Pharmaceuticals media release.
- 13 Jul 2009 New trial record.